980 related articles for article (PubMed ID: 36034698)
1. Curcumin-driven reprogramming of the gut microbiota and metabolome ameliorates motor deficits and neuroinflammation in a mouse model of Parkinson's disease.
Cui C; Han Y; Li H; Yu H; Zhang B; Li G
Front Cell Infect Microbiol; 2022; 12():887407. PubMed ID: 36034698
[TBL] [Abstract][Full Text] [Related]
2. The protective role of microbiota in the prevention of MPTP/P-induced Parkinson's disease by resveratrol.
Tao J; An Y; Xu L; Wang Y; Wang C; Li P; Li M; Yan D; Wang M; Zhong G; Wu M
Food Funct; 2023 May; 14(10):4647-4661. PubMed ID: 37102320
[TBL] [Abstract][Full Text] [Related]
3. Rubusoside mitigates neuroinflammation and cellular apoptosis in Parkinson's disease, and alters gut microbiota and metabolite composition.
Meng T; Zhang Y; Huang J; Pandey V; Fu S; Ma S
Phytomedicine; 2024 Feb; 124():155309. PubMed ID: 38237261
[TBL] [Abstract][Full Text] [Related]
4. Effect of Coffee against MPTP-Induced Motor Deficits and Neurodegeneration in Mice Via Regulating Gut Microbiota.
Liu J; Zhang Y; Ye T; Yu Q; Yu J; Yuan S; Gao X; Wan X; Zhang R; Han W; Zhang Y
J Agric Food Chem; 2022 Jan; 70(1):184-195. PubMed ID: 35016506
[TBL] [Abstract][Full Text] [Related]
5. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Induced Parkinson's Disease in Mouse: Potential Association between Neurotransmitter Disturbance and Gut Microbiota Dysbiosis.
Zhu Y; Huan F; Wang J; Xie X; Yu G; Wang X; Jiang L; Gao R; Xiao H; Ding H; Wang J
ACS Chem Neurosci; 2020 Oct; 11(20):3366-3376. PubMed ID: 32926778
[TBL] [Abstract][Full Text] [Related]
6. N-acetyl-L-leucine protects MPTP-treated Parkinson's disease mouse models by suppressing Desulfobacterota via the gut-brain axis.
Xu Z; Lian C; Pan L; Lai W; Zhang F; Peng L; Zhou S; Zhao G; Yang X; Zhang G; Tan Z; Wang Y
Brain Res Bull; 2023 Oct; 202():110729. PubMed ID: 37579888
[TBL] [Abstract][Full Text] [Related]
7. A Low-Protein, High-Carbohydrate Diet Exerts a Neuroprotective Effect on Mice with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Parkinson's Disease by Regulating the Microbiota-Metabolite-Brain Axis and Fibroblast Growth Factor 21.
Chu C; Li T; Yu L; Li Y; Li M; Guo M; Zhao J; Zhai Q; Tian F; Chen W
J Agric Food Chem; 2023 Jun; 71(23):8877-8893. PubMed ID: 37267589
[TBL] [Abstract][Full Text] [Related]
8. The intestinal microbiota exerts a sex-specific influence on neuroinflammation in a Parkinson's disease mouse model.
Zhou X; Gao Y; Wei J; Luo J; Wang Y; Yue M; Wang B; Hong D; Chen T; Fang X
Neurochem Int; 2024 Feb; 173():105661. PubMed ID: 38157887
[TBL] [Abstract][Full Text] [Related]
9. Intestinal Pathology and Gut Microbiota Alterations in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Mouse Model of Parkinson's Disease.
Lai F; Jiang R; Xie W; Liu X; Tang Y; Xiao H; Gao J; Jia Y; Bai Q
Neurochem Res; 2018 Oct; 43(10):1986-1999. PubMed ID: 30171422
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective Effects of Sodium Butyrate by Restoring Gut Microbiota and Inhibiting TLR4 Signaling in Mice with MPTP-Induced Parkinson's Disease.
Guo TT; Zhang Z; Sun Y; Zhu RY; Wang FX; Ma LJ; Jiang L; Liu HD
Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839287
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor 21 ameliorates behavior deficits in Parkinson's disease mouse model via modulating gut microbiota and metabolic homeostasis.
Yang C; Wang W; Deng P; Wang X; Zhu L; Zhao L; Li C; Gao H
CNS Neurosci Ther; 2023 Dec; 29(12):3815-3828. PubMed ID: 37334756
[TBL] [Abstract][Full Text] [Related]
12. Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis.
Zhao Z; Ning J; Bao XQ; Shang M; Ma J; Li G; Zhang D
Microbiome; 2021 Nov; 9(1):226. PubMed ID: 34784980
[TBL] [Abstract][Full Text] [Related]
13. Curcumin alleviates 1-methyl- 4-phenyl- 1,2,3,6-tetrahydropyridine- induced Parkinson's disease in mice via modulating gut microbiota and short-chain fatty acids.
Cai B; Zhong L; Wang Q; Xu W; Li X; Chen T
Front Pharmacol; 2023; 14():1198335. PubMed ID: 37388445
[No Abstract] [Full Text] [Related]
14. Probiotic Clostridium butyricum ameliorated motor deficits in a mouse model of Parkinson's disease via gut microbiota-GLP-1 pathway.
Sun J; Li H; Jin Y; Yu J; Mao S; Su KP; Ling Z; Liu J
Brain Behav Immun; 2021 Jan; 91():703-715. PubMed ID: 33148438
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway.
Sun MF; Zhu YL; Zhou ZL; Jia XB; Xu YD; Yang Q; Cui C; Shen YQ
Brain Behav Immun; 2018 May; 70():48-60. PubMed ID: 29471030
[TBL] [Abstract][Full Text] [Related]
16. Vancomycin Pretreatment on MPTP-Induced Parkinson's Disease Mice Exerts Neuroprotection by Suppressing Inflammation Both in Brain and Gut.
Cui C; Hong H; Shi Y; Zhou Y; Qiao CM; Zhao WJ; Zhao LP; Wu J; Quan W; Niu GY; Wu YB; Li CS; Cheng L; Hong Y; Shen YQ
J Neuroimmune Pharmacol; 2023 Jun; 18(1-2):72-89. PubMed ID: 35091889
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiota-derived propionate mediates the neuroprotective effect of osteocalcin in a mouse model of Parkinson's disease.
Hou YF; Shan C; Zhuang SY; Zhuang QQ; Ghosh A; Zhu KC; Kong XK; Wang SM; Gong YL; Yang YY; Tao B; Sun LH; Zhao HY; Guo XZ; Wang WQ; Ning G; Gu YY; Li ST; Liu JM
Microbiome; 2021 Jan; 9(1):34. PubMed ID: 33517890
[TBL] [Abstract][Full Text] [Related]
18. 5-HT4 Receptor is Protective for MPTP-induced Parkinson's Disease Mice Via Altering Gastrointestinal Motility or Gut Microbiota.
Cui C; Shi Y; Hong H; Zhou Y; Qiao C; Zhao L; Jia X; Zhao W; Shen Y
J Neuroimmune Pharmacol; 2023 Dec; 18(4):610-627. PubMed ID: 37782386
[TBL] [Abstract][Full Text] [Related]
19. Intragastric Administration of Casein Leads to Nigrostriatal Disease Progressed Accompanied with Persistent Nigrostriatal-Intestinal Inflammation Activited and Intestinal Microbiota-Metabolic Disorders Induced in MPTP Mouse Model of Parkinson's Disease.
Liu X; Liu S; Tang Y; Pu Z; Xiao H; Gao J; Yin Q; Jia Y; Bai Q
Neurochem Res; 2021 Jun; 46(6):1514-1539. PubMed ID: 33719004
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotection of chicoric acid in a mouse model of Parkinson's disease involves gut microbiota and TLR4 signaling pathway.
Wang N; Feng BN; Hu B; Cheng YL; Guo YH; Qian H
Food Funct; 2022 Feb; 13(4):2019-2032. PubMed ID: 35103734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
